Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dubin & Co. is a New York-based private investment firm and family office founded by Glenn Dubin. The firm operates as a multi-strategy investment vehicle with a significant concentration in the life sciences, biotechnology, and healthcare sectors. Dubin & Co. is notably recognized for its proactive role in company creation, having co-founded Castle Creek Biosciences and maintaining a strategic partnership with Paragon Biosciences. The firm focuses on identifying and scaling transformative medical technologies, particularly within gene therapy and treatments for rare dermatological and orphan diseases. By providing both capital and executive guidance, Dubin & Co. supports the development of therapies from early-stage research through late-stage clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dubin & Co..